中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
7期
64-65
,共2页
巴曲酶%突发性耳聋%有效性%药理作用
巴麯酶%突髮性耳聾%有效性%藥理作用
파곡매%돌발성이롱%유효성%약리작용
Batroxobin%Sudden deafness%Validity%Pharmacological effects
目的观察巴曲酶治疗突发性耳聋的有效性,并分析其药理作用,以供临床借鉴和参考.方法以2009年9月至2012年8月在我院耳鼻喉科接受治疗的突发性耳聋患者135例为研究对象,进行随机分组,均给予常规综合治疗.观察组同时给予巴曲酶静脉滴注.观察两组患者听力恢复情况,并比较治疗前后凝血功能各指标的差异.结果与对照组相比较,观察组听力恢复情况明显较好,有显著的统计学差异(P<0.05).与治疗前相比较,观察组凝血功能有明显改善,有显著的统计学差异(P<0.05).对照组治疗前后凝血功能无明显差异(P>0.05).结论采用巴曲酶治疗突发性耳聋临床疗效较为满意,对患者的康复具有积极的促进作用,值得临床推广.
目的觀察巴麯酶治療突髮性耳聾的有效性,併分析其藥理作用,以供臨床藉鑒和參攷.方法以2009年9月至2012年8月在我院耳鼻喉科接受治療的突髮性耳聾患者135例為研究對象,進行隨機分組,均給予常規綜閤治療.觀察組同時給予巴麯酶靜脈滴註.觀察兩組患者聽力恢複情況,併比較治療前後凝血功能各指標的差異.結果與對照組相比較,觀察組聽力恢複情況明顯較好,有顯著的統計學差異(P<0.05).與治療前相比較,觀察組凝血功能有明顯改善,有顯著的統計學差異(P<0.05).對照組治療前後凝血功能無明顯差異(P>0.05).結論採用巴麯酶治療突髮性耳聾臨床療效較為滿意,對患者的康複具有積極的促進作用,值得臨床推廣.
목적관찰파곡매치료돌발성이롱적유효성,병분석기약리작용,이공림상차감화삼고.방법이2009년9월지2012년8월재아원이비후과접수치료적돌발성이롱환자135례위연구대상,진행수궤분조,균급여상규종합치료.관찰조동시급여파곡매정맥적주.관찰량조환자은력회복정황,병비교치료전후응혈공능각지표적차이.결과여대조조상비교,관찰조은력회복정황명현교호,유현저적통계학차이(P<0.05).여치료전상비교,관찰조응혈공능유명현개선,유현저적통계학차이(P<0.05).대조조치료전후응혈공능무명현차이(P>0.05).결론채용파곡매치료돌발성이롱림상료효교위만의,대환자적강복구유적겁적촉진작용,치득림상추엄.
@@@@Objective Observe effect of Batroxobin in treatment of sudden deafness, analyse its pharmacological effect for clinical reference. Methods Choose 135 cases from September 2009 to August 2012 in our hospital as research object, divided randomLy into 2 groups, given routine treatment. Observation group given batroxobin. Observed hearing recovery of the 2 group, and compared before and after treatment of coagulation indexes. Results Compared with control group, observation group was significantly better hearing recovery, with significant statistical difference (P<0.05). Compared with before treatment, observation group coagulation function were obviously improved, with significant statistical difference (P<0.05). Control group before and after treatment coagulation function had no significant difference (P>0.05). Conclusion Batroxobin in treatment of sudden deafness clinical effect is satisfied, stimulate the rehabilitation, worthy of clinical application.